JP2022526553A5 - - Google Patents
Info
- Publication number
- JP2022526553A5 JP2022526553A5 JP2021557759A JP2021557759A JP2022526553A5 JP 2022526553 A5 JP2022526553 A5 JP 2022526553A5 JP 2021557759 A JP2021557759 A JP 2021557759A JP 2021557759 A JP2021557759 A JP 2021557759A JP 2022526553 A5 JP2022526553 A5 JP 2022526553A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- substituted
- pharmaceutically acceptable
- acceptable salt
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1904375.1 | 2019-03-29 | ||
| GBGB1904375.1A GB201904375D0 (en) | 2019-03-29 | 2019-03-29 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| PCT/EP2020/058061 WO2020200898A1 (en) | 2019-03-29 | 2020-03-24 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526553A JP2022526553A (ja) | 2022-05-25 |
| JP2022526553A5 true JP2022526553A5 (cg-RX-API-DMAC7.html) | 2023-04-06 |
Family
ID=66442789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557759A Pending JP2022526553A (ja) | 2019-03-29 | 2020-03-24 | 炎症性障害の治療のための新規化合物及びその医薬組成物 |
Country Status (14)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA54755A (fr) * | 2019-01-18 | 2021-11-24 | Biogen Ma Inc | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 |
| GB201904373D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904374D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
| KR20230059584A (ko) | 2021-10-26 | 2023-05-03 | 주식회사 엘지에너지솔루션 | 전극 조립체의 제조방법 |
| WO2023098857A1 (zh) * | 2021-12-03 | 2023-06-08 | 武汉人福创新药物研发中心有限公司 | Irak4抑制剂及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1657242A4 (en) * | 2003-08-15 | 2008-10-29 | Banyu Pharma Co Ltd | imidazopyridine |
| JPWO2005108399A1 (ja) * | 2004-05-10 | 2008-03-21 | 萬有製薬株式会社 | イミダゾピリジン化合物 |
| US9169260B2 (en) * | 2011-03-22 | 2015-10-27 | Merck Sharp & Dohme Corp. | Amidopyrazole inhibitors of interleukin receptor-associated kinases |
| RU2675818C2 (ru) * | 2013-03-14 | 2018-12-25 | Галапаго Нв | Новые соединения и фармацевтические композиции, их содержащие, для лечения воспалительных расстройств |
| EP3092226B1 (en) * | 2014-01-10 | 2019-03-13 | Aurigene Discovery Technologies Limited | Indazole compounds as irak4 inhibitors |
| CN108473498B (zh) * | 2015-12-22 | 2021-11-02 | 豪夫迈·罗氏有限公司 | 作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物 |
| WO2018060174A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln |
| WO2018060072A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| CN110835338A (zh) * | 2018-08-17 | 2020-02-25 | 浙江海正药业股份有限公司 | 咪唑并吡啶类衍生物及其制备方法和其在医药上的用途 |
| MA54755A (fr) * | 2019-01-18 | 2021-11-24 | Biogen Ma Inc | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 |
| GB201904373D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904374D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
-
2019
- 2019-03-29 GB GBGB1904375.1A patent/GB201904375D0/en not_active Ceased
-
2020
- 2020-03-24 KR KR1020217035256A patent/KR20210143905A/ko not_active Withdrawn
- 2020-03-24 BR BR112021019099A patent/BR112021019099A2/pt not_active Application Discontinuation
- 2020-03-24 MX MX2021011574A patent/MX2021011574A/es unknown
- 2020-03-24 AU AU2020252900A patent/AU2020252900A1/en not_active Abandoned
- 2020-03-24 US US17/599,447 patent/US20220296573A1/en not_active Abandoned
- 2020-03-24 JP JP2021557759A patent/JP2022526553A/ja active Pending
- 2020-03-24 CA CA3134732A patent/CA3134732A1/en active Pending
- 2020-03-24 SG SG11202110643YA patent/SG11202110643YA/en unknown
- 2020-03-24 EP EP20714521.0A patent/EP3947374A1/en not_active Withdrawn
- 2020-03-24 WO PCT/EP2020/058061 patent/WO2020200898A1/en not_active Ceased
- 2020-03-24 CN CN202080026038.XA patent/CN113677678A/zh active Pending
- 2020-03-24 PH PH1/2021/552377A patent/PH12021552377A1/en unknown
-
2021
- 2021-09-26 IL IL286688A patent/IL286688A/en unknown